TurtleTree set to commercialize human lactoferrin as first major cell-based product

By Jim Cornall contact

- Last updated on GMT

TurtleTree's cell-based technology has recreated the human-optimized protein from the blueprint of human milk. Pic: TurtleTree
TurtleTree's cell-based technology has recreated the human-optimized protein from the blueprint of human milk. Pic: TurtleTree

Related tags: lactoferrin

TurtleTree, producer of cell-based milk, is preparing for the launch of its first commercially-scalable product, human lactoferrin.

The company said while it will take several years before cell-based whole milk passes regulatory requirements, it has chosen to be commercially focused by exploring the field of milk ingredients.

Max Rye, chief strategist of TurtleTree, said, "We have been able to identify early commercial ingredient targets due to our frequent conversations with prominent  performance nutrition and infant formula companies. We've since seen tremendous interest from global partners in our portfolio of human and bovine milk products. It is going to be an exciting year for us."

Lactoferrin has been gaining traction recently in studies showing its value in boosting resistance to infections from blocking the Covid-19 virus to fighting off bad bacteria in the gut and viral infections. Lactoferrin is an important compound for babies' early protection. Its concentration in human milk is five times higher than in cow milk, although human colostrum has the highest amount of 5-6g/L.

Besides providing protection, lactoferrin also plays an important role in brain development and inflammation responses. Gaining traction for adult and senior health, today it is used for treating stomach and intestinal ulcers, diarrhea, hepatitis C and regulating the way the body processes iron.

TurtleTree's cell-based technology has recreated the human-optimized protein from the blueprint of human milk, which the company said makes it more accessible to everyone without relying on cattle farming.

Related news

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us

Products

View more

Webinars